Method for diagnosing non-small cell lung carcinoma
First Claim
1. A method for treating non-small cell lung carcinoma in a patient with tumor cells that are resistant to Hedgehog pathway antagonists comprising administering to a patient with non-small cell lung carcinoma tumor cells that are resistant to Hedgehog pathway antagonists, an inhibitor of Gli1 in combination with Compound 6 thereby treating the non-small cell lung carcinoma in the patient.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the constitutive activity of the Hedgehog pathway in non-small cell lung carcinoma (NSCLC). A method for diagnosing NSCLC by detecting the level of a component of the Hedgehog pathway is provided, as is a method for identifying subjects that will respond positively to treatment with a Hedgehog pathway antagonist. Methods for treating subjects with cancer or cancers resistant to Hedgehog pathway antagonists are also provided.
-
Citations
1 Claim
-
1. A method for treating non-small cell lung carcinoma in a patient with tumor cells that are resistant to Hedgehog pathway antagonists comprising administering to a patient with non-small cell lung carcinoma tumor cells that are resistant to Hedgehog pathway antagonists, an inhibitor of Gli1 in combination with Compound 6 thereby treating the non-small cell lung carcinoma in the patient.
Specification